CoChat

Investigating the Heterogeneity in Women’s Preferences for Breast Screening: Does the Communication of Risk Matter?

Vass, Caroline M., Rigby, Dan, Payne, Katherine · 2018 · Value in Health
Cited by 33

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jval.2017.07.010

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 51

  1. von Karsa, 2008, Cancer screening in the European Union, Report on the implementation of the Council Recommendation on cancer screening
  2. Torjesen, 2015, How much is too much breast screening?, BMJ, 350, h139, 10.1136/bmj.h139 · doi:10.1136/bmj.h139
  3. Bleyer, 2012, Effect of three decades of screening mammography on breast-cancer incidence, N Engl J Med, 367, 1998, 10.1056/NEJMoa1206809 · DOI · Paper page
  4. Moss, 2015, Effect of mammographic screening from age 40 years on breast cancer mortality in the UK Age trial at 17 years’ follow-up: a randomised controlled trial, Lancet Oncol, 16, 1123, 10.1016/S1470-2045(15)00128-X · doi:10.1016/s1470-2045(15)00128-x
  5. Liston, 2003, Can the NHS Breast Screening Programme afford not to double read screening mammograms?, Clin Radiol, 58, 474, 10.1016/S0009-9260(03)00063-1 · DOI
  6. Welch, 2010, Overdiagnosis in cancer, J Natl Cancer Inst, 102, 605, 10.1093/jnci/djq099 · DOI · Paper page
  7. Hofvind, 2004, The cumulative risk of a false-positive recall in the Norwegian Breast Cancer Screening Program, Cancer, 101, 1501, 10.1002/cncr.20528 · doi:10.1002/cncr.20528
  8. Baum, 2013, Harms from breast cancer screening outweigh benefits if death caused by treatment is included, BMJ, 346, f385, 10.1136/bmj.f385 · DOI
  9. Kirwan, 2013, Breast cancer screening: What does the future hold?, BMJ, 346, f87, 10.1136/bmj.f87 · doi:10.1136/bmj.f87
  10. Pace, 2014, A systematic assessment of benefits and risks to guide breast cancer screening decisions, JAMA, 311, 1327, 10.1001/jama.2014.1398 · DOI · Paper page
  11. Gøtzsche, 2011, Screening for breast cancer with mammography (review), Cochrane Database Syst Rev, 10.1002/14651858.CD001877.pub4 · DOI · Paper page
  12. Mansfield, 2016, Stated preference for cancer screening: a systematic review of the literature, 1990–2013, Prev Chronic Dis, 13, E27, 10.5888/pcd13.150433 · DOI
  13. Gerard, 2003, Using stated preference discrete choice modelling to inform health care decision-making: a pilot study of breast screening participation, Appl Econ, 35, 1073, 10.1080/0003684032000081348 · DOI · Paper page
  14. Clark, 2014, Discrete choice experiments in health economics: a review of the literature, Pharmacoeconomics, 32, 883, 10.1007/s40273-014-0170-x · DOI · Paper page
  15. Lancaster, 1966, A new approach to consumer theory, J Polit Econ, 74, 132, 10.1086/259131 · DOI · Paper page
  16. Thurstone, 1927, A law of comparative judgment, Psychol Rev, 34, 273, 10.1037/h0070288 · DOI · Paper page
  17. Lancsar, 2005, Discrete choice experiments in health economics: distinguishing between the method and its application, Eur J Health Econ, 6, 314, 10.1007/s10198-005-0304-3 · DOI
  18. Harrison, 2014, Risk as an attribute in discrete choice experiments: a critical review, Patient, 7, 151, 10.1007/s40271-014-0048-1 · DOI
  19. Hauber, 2013, Quantifying benefit-risk preferences for medical interventions: an overview of a growing empirical literature, Appl Health Econ Health Policy, 11, 319, 10.1007/s40258-013-0028-y · DOI
  20. Ho, 2015, Incorporating patient-preference evidence into regulatory decision making, Surg Endosc, 29, 2984, 10.1007/s00464-014-4044-2 · DOI · Paper page
  21. Lipkus, 2007, Numeric, verbal, and visual formats of conveying health risks: suggested best practices and future recommendations, Med Decis Making, 27, 696, 10.1177/0272989X07307271 · DOI · Paper page
  22. Price, 2007, Communicating risk information: the influence of graphical display format on quantitative information perception—accuracy, comprehension and preferences, Patient Educ Couns, 69, 121, 10.1016/j.pec.2007.08.006 · DOI
  23. Galesic, 2009, Using icon arrays to communicate medical risks: overcoming low numeracy, Health Psychol, 28, 210, 10.1037/a0014474 · DOI · Paper page
  24. Hole, 2008, Modelling heterogeneity in patients’ preferences for the attributes of a general practitioner appointment, J Health Econ, 27, 1078, 10.1016/j.jhealeco.2007.11.006 · DOI · Paper page
  25. Mayor, 2010, Critics attack new NHS breast screening leaflet for failing to address harms, BMJ, 341, c7267, 10.1136/bmj.c7267 · doi:10.1136/bmj.c7267
  26. Gøtzsche, 2011, The breast screening programme and misinforming the public, J R Soc Med, 104, 361, 10.1258/jrsm.2011.110078 · doi:10.1258/jrsm.2011.110078
  27. BreastHealth, 2014, Private breast screening and diagnostic service prices.
  28. Welch, 2011, Likelihood that a woman with screen-detected breast cancer has had her “life saved” by that screening, Arch Intern Med, 171, 2043, 10.1001/archinternmed.2011.476 · DOI
  29. Hall, 2014, Implementing risk-stratified screening for common cancers: a review of potential ethical, legal and social issues, J Public Health (Oxf), 36, 285, 10.1093/pubmed/fdt078 · DOI
  30. Independent, 2012, Panel on Breast Cancer Screening. The benefits and harms of breast cancer screening: an independent review, Lancet, 380, 1778, 10.1016/S0140-6736(12)61611-0 · DOI · Paper page
  31. Taylor-Phillips, 2013, The effects of a UK review of breast cancer screening on uptake: an observational before/after study, J Med Screen, 20, 86, 10.1177/0969141313497198 · DOI
  32. Vass, 2014, Investigating the framing of risk attributes in a discrete choice experiment: an application of eye-tracking and think aloud, Med Decis Making, 35, E99
  33. Evans, 1994, The impact of genetic counselling on risk perception in women with a family history of breast cancer, Br J Cancer, 70, 934, 10.1038/bjc.1994.423 · DOI · Paper page
  34. Evans, 1993, Perception of risk in women with a family history of breast cancer, Br J Cancer, 67, 612, 10.1038/bjc.1993.112 · DOI · Paper page
  35. Schwartz, 1997, The role of numeracy in understanding the benefit of screening mammography, Ann Intern Med, 127, 1023, 10.7326/0003-4819-127-11-199712010-00003 · DOI · Paper page
  36. Fiebig, 2010, The generalized multinomial logit model: accounting for scale and coefficient heterogeneity, Mark Sci, 29, 393, 10.1287/mksc.1090.0508 · DOI · Paper page
  37. Swait, 1993, The role of the scale parameter in the estimation and comparison of multinomial logit models, J Mark Res, 30, 305, 10.1177/002224379303000303 · DOI · Paper page
  38. Dziak, 2012, Sensitivity and specificity of information criteria, Methodol Cent Tech Rep Ser Pennsylvania State University
  39. Shen, 2009, Latent class model or mixed logit model? A comparison by transport mode choice data, Appl Econ, 41, 2915, 10.1080/00036840801964633 · DOI · Paper page
  40. Flynn, 2010, Using discrete choice experiments to understand preferences for quality of life: variance-scale heterogeneity matters, Soc Sci Med, 70, 1957, 10.1016/j.socscimed.2010.03.008 · DOI
  41. Hoare, 1996, Breast screening and ethnic minorities, Br J Cancer Suppl, 29, S38
  42. Renshaw, 2010, Estimating attendance for breast cancer screening in ethnic groups in London, BMC Public Health, 10, 1, 10.1186/1471-2458-10-157 · doi:10.1186/1471-2458-10-157
  43. Bansal, 2012, Major ethnic group differences in breast cancer screening uptake in Scotland are not extinguished by adjustment for indices of geographical residence, area deprivation, long-term illness and education, Br J Cancer, 106, 1361, 10.1038/bjc.2012.83 · DOI
  44. Bell, 1999, Interventions to improve uptake of breast screening in inner city Cardiff general practices with ethnic minority lists, Ethn Health, 4, 277, 10.1080/13557859998056 · DOI
  45. 2016, Breast Screening Programme, England Statistics for 2014-15.
  46. Veldwijk, 2016, Survival or mortality: Does risk attribute framing influence decision-making behavior in a discrete choice experiment?, Value Health, 19, 202, 10.1016/j.jval.2015.11.004 · DOI
  47. Peters, 2014, Numbers matter to informed patient choices, Med Decis Making, 34, 430, 10.1177/0272989X13511705 · DOI
  48. Barratt, 2015, Overdiagnosis in mammography screening: a 45 year journey from shadowy idea to acknowledged reality, BMJ, 350, h867, 10.1136/bmj.h867 · DOI
  49. Hersch, 2013, Women’s views on overdiagnosis in breast cancer screening: a qualitative study, BMJ, 346, 1, 10.1136/bmj.f158 · DOI · Paper page
  50. Dennis, 2001, Are internet panels creating professional respondents?, Mark Res, 13, 34
  51. Grutters, 2008, Willingness to accept versus willingness to pay in a discrete choice experiment, Value Health, 11, 1110, 10.1111/j.1524-4733.2008.00340.x · DOI

Metadata

Authors
Vass, C. M., Rigby, D., & Payne, K.
Venue
Value in Health
Publisher
Elsevier BV
Published
2018-02
Volume
21
Issue
2
Pages
219-228
ISSN
1098-3015
Cited by
33
References
7
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.